Jammi Pharmaceuticals Private Limited, a active private limited company, was established on 02 May 2018 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U85310TN2018PTC122433. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹3.15 M.
It upholds a compliant status. Employing 42 professional, Its leadership includes Jammi Venkata Badari Lakshmi Narasimham (Director), Anitha Balachander (Additional Director). Past directors included Jammi Venkata Butchi Lakshmirama Narasu. It holds ₹1.70 Cr open charges and ₹8.05 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Abhirami Apartments, Old No 20, New No 14, Flat No 2B, 2Nd Floor, Dr Nair Road, T Nagar, Chennai, Tamil Nadu, 600017.
U85310TN2018PTC122433
122433
02 May 2018
₹3.50 M
₹3.15 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Jammi Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jammi Venkata Badari Lakshmi Narasimham | Director | 02 May 2018 | Current |
| Anitha Balachander | Additional Director | 07 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jammi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.14% increase. The company also saw a substantial improvement in profitability, with a 56% increase in profit. The company's net worth moved up by a moderate rise of 4.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jammi Pharmaceuticals had a public holding of 20.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹16,963,000.00
₹8,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2025 | Bank Of India | ₹1.70 Cr | Open |
| 10 Aug 2022 | Others | ₹8.05 M | Satisfied |
Explore comprehensive loan charge details -
Jammi Pharmaceuticals has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jammi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jammi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 10 Aug 2022 via Charge ID 100610298 with Others was fully satisfied on 30 Sep 2025. was completed.
A charge with Bank Of India amounted to Rs. 16.96 M with Charge ID 101169769 was registered on 23 Sep 2025. was recorded as a recent event.
Progress on Jammi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Jammi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge with Others amounted to Rs. 8.05 M with Charge ID 100610298 was registered on 10 Aug 2022. was completed.
Progress on Anitha Balachander was appointed as a Additional Director was appointed as a Additional Director on 07 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
The CIN of Jammi Pharmaceuticals Private Limited is U85310TN2018PTC122433.
Jammi Pharmaceuticals Private Limited is headquartered at Abhirami Apartments, Old No 20, New No 14, Flat No 2B, 2Nd Floor, Dr Nair Road, T Nagar, Chennai, Tamil Nadu, 600017.
Jammi Pharmaceuticals Private Limited was incorporated on 02 May 2018.
The current directors of Jammi Pharmaceuticals Private Limited are
The primary industry of Jammi Pharmaceuticals Private Limited is Hospital And Medical Care.
Jammi Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jammi Pharmaceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹3.15 M.
The compliance status of Jammi Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX